Research Paper Volume 13, Issue 16 pp 20438—20467
Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer
Figure 2. Relationship between ceruloplasmin mRNA expression and clinicopathological features of BRCA patients. Ceruloplasmin expression was estimated in BRCA patients according to (A) sex, (B) different cancer stages, (C) different nodal metastasis statuses, (D) major BRCA subclasses, (E) age and (F) menopausal status. *<0.05, **<0.01, ***<0.001.